Skip to content
HowShorted

InspireMD Inc. short interest in 2022

In 2022, InspireMD Inc.'s disclosed short interest ran from 2.24% of shares outstanding on 14 Jan 2022 to 0.13% on 30 Dec 2022, a change of -2.11 percentage points. The year's high was 2.55% on 15 Feb 2022 and its low 0.13% on 15 Aug 2022, averaging 0.81% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.52 days on 15 Feb 2022. Full history: InspireMD Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for InspireMD Inc. in 2022

2022 in figures

Start of year
2.24% (14 Jan 2022)
End of year
0.13% (30 Dec 2022)
Change
-2.11 pp
High
2.55% (15 Feb 2022)
Low
0.13% (15 Aug 2022)
Average
0.81%
Highest days to cover
7.52 (15 Feb 2022)
SEC filings marked
8

Every report in 2022

InspireMD Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20222.24%3.19
31 Jan 20222.46%3.27
15 Feb 20222.55%7.52
28 Feb 20222.25%6.75
15 Mar 20221.43%4.5210-K filed, results (8-K)
31 Mar 20221.33%4.48
14 Apr 20221.06%5.57
29 Apr 20220.98%4.54
13 May 20220.84%1.9010-Q filed, results (8-K)
31 May 20220.76%4.55
15 Jun 20220.40%2.64
30 Jun 20220.52%4.36
15 Jul 20220.45%5.08
29 Jul 20220.38%2.66
15 Aug 20220.13%1.0010-Q filed, results (8-K)
31 Aug 20220.16%1.00
15 Sep 20220.16%1.00
30 Sep 20220.15%1.00
14 Oct 20220.15%1.00
31 Oct 20220.16%1.00
15 Nov 20220.15%1.0010-Q filed, results (8-K)
30 Nov 20220.36%1.36
15 Dec 20220.19%1.00
30 Dec 20220.13%1.00

See also: InspireMD Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.